The new site for all the latest news from the European Cancer Stem cell Research Institute (@ECSCRI).
Cardiff, Wales
Joined June 2010
- Tweets1.7K
- Following809
- Followers1.6K
- Likes175
The Root of the Problem: Prof Richard Clarkson focusesing on c-FLIP/ BCL3 as key survival mechanisms in cancer stem cells. It explores their roles in blocking apoptosis, driving resistance and metastasis, plus lab-to-clinic translation strategies. open.spotify.com/episode/32M…
Cancer Stem Cells: The Root of the Problem - Podcast Episode 3- Dr Phesse covers Fzd7 as a therapy, from gene editing to mouse models, translational challenges and advice for students entering cancer research.open.spotify.com/episode/6BC…
ECSCRI PODCAST - EPISODE 2 “Cancer Stem Cells in the Clinic - This episode examines how cancer stem cells drive treatment resistance, relapse and metastasis.
open.spotify.com/episode/1rN…
ECSCRI retweeted
In #HeartMonth and on #WearRedDay I am pleased to announce a new PhD studentship in my lab to study and develop novel therapies to target cardiovascular disease development, application deadline March 6 for a October 2026 start, please RX:
eur03.safelinks.protection.o…
“Cancer Stem Cells: The Root of the Problem” - a new 6-episode podcast series from ECSCRI.
Episode 1
open.spotify.com/show/34sFhq…
@CUBLSResearch @CUBiosciences @theWCRC @CardiffCancer
Coming this week....Cancer Stem Cells: The root of the problem.
Welcome to a new series of posters and podcasts explaining cancer stem cells, their importance to treatment and insight into our latest research. Created by Alexandra Totolici our talented Y3 student @CUBiosciences
Want to understand cutting-edge cancer research happening right here at ECSCRI?
We’re recruiting ALL undergraduate students for a quick science communication study. Learn about ECSCRI and get a participation certificate for your CV!
Fully confidential: forms.gle/5ikfGHreBcrSeBiX8
Hi, head on over to our new LinkedIn page for latest devopments at linkedin.com/company/europea…
Congratulations to ECSCRI's Dr Toby Phesse who has been awarded major funding from PCUK, with Prof. Karl Willert (University California San Diego) to determine the therapeutic benefit of a new drug targeting FZD7 in advanced prostate cancer. @CUBiosciences @CUBLSResearch @theWCRC
Cardiff ECMC Community Day Tuesday 25th November - Open Call for Workshop Ideas
A series of presentations highlighting Early Phase and Translational and break out groups to pitch/develop new research ideas. See [email protected] linkedin.com/feed/update/urn…
ECSCRI retweeted
We collaborate across the college @CUBLSResearch including blood cancer research which is a high priority. The division works closely with @ECSCRI and @NRodriguesLab as well as colleagues form @CTRCardiffUni and @PharmacyCU, @CRGHaem, and NHS partners
ECSCRI retweeted
In May, we are fundraising for @cancer_wales Brain Tumour Research Initiative!
17 brain cancer researchers/clinicians/supporters are going the extra mile to beat brain cancer!
Please consider supporting us: justgiving.com/page/extra-mi…
Latest paper from Parry (ECSCRI) and Dyson (Swansea University) highlighting key considerations for modelling gut:bacteria interactions with organoids.@CUBLSResearch @CUBiosciences @theWCRC @MDPIOpenAccess @CRUKCymru
On Monday the Phesse lab attended the WntUK conference in Oxford, with PhD student Kieran Hodson winning the Best Poster Prize. L-R Jess Hembrough, Toby Phesse, Kieran Hodson, Will Humphrey. See lnkd.in/etFBRpzY
ECSCRI retweeted
Dr @BeaSalvaBarbe at @cardiffuni @ecscri is investigating the very earliest changes that take place in the development of pancreatic cancer, with the hope of improving early detection.
ECSCRI retweeted
This month we invited Members of the Senedd to visit @ECSCRI at @cardiffuni to see some of the ground-breaking research we’re funding. They met Prof Richard Clarkson and his team, who are working to understand how triple negative breast cancer can become resistant to chemo.
ALT Hannah Blythyn in conversation with Prof Richard Clarkson.
ECSCRI's Dr Helen Pearson proudly helping @ProstateCymru launch their Eddie Butler PhD scholarship initiative to progress vital research and advance treatment @CUBLSResearch @theWCRC @CUBiosciences xitter.cf/ProstateCymru/status/1…
ECSCRI welcomes Breast Cancer Now staff, patients & fundraisers, and members of the Welsh Senedd to learn about the latest breast cancer research at ECSCRI. @CUBiosciences @CUBLSResearch @theWCRC @BreastCancerNow @SeneddWales @seneddhealth
Remember to follow us on LinkedIn as well. linkedin.com/groups/8100547/